EcoR1 Capital Fund Qualified, L.P.'s Net Worth

$83.2 Million

Estimate Recalculated Sep 17, 2024 08:13PM EST

Who is EcoR1 Capital Fund Qualified, L.P.

EcoR1 Capital Fund Qualified, L.P. has an estimated net worth of $83.2 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Kura Oncology, Inc., Panacea Acquisition Corp. II, ASSEMBLY BIOSCIENCES, INC., aTYR PHARMA INC, and GENVEC INC.

SEC CIK

EcoR1 Capital Fund Qualified, L.P.'s CIK is 0001598292

Past Insider Trading and Trends

2018 was EcoR1 Capital Fund Qualified, L.P.'s most active year for acquiring shares with 10 total transactions. EcoR1 Capital Fund Qualified, L.P.'s most active month to acquire stocks was the month of November. 2017 was EcoR1 Capital Fund Qualified, L.P.'s most active year for disposing of shares, totalling 4 transactions. EcoR1 Capital Fund Qualified, L.P.'s most active month to dispose stocks was the month of October. 2018 saw EcoR1 Capital Fund Qualified, L.P. paying a total of $5,092,767.97 for 375,545 shares, this is the most they've acquired in one year. In 2018 EcoR1 Capital Fund Qualified, L.P. cashed out on 3,235,836 shares for a total of $3,349,119.65, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nuvation Bio Inc.

Investor
Updated Sep 22, 2023
Form 4/A
72.17%
5.31M
$1.26
$6.69M
Sep 22, 2023
12.67M
Purchase
Sep 19 - Sep 21
Form 4
72.17%
5.31M
$1.26
$6.69M
Sep 21, 2023
19.21M
Purchase
Feb 19 - Feb 21
Form 4
3.07%
488.11K
$8.89
$4.59M
Nov 30, 2021
21.78M
Purchase
Mar 31 - Nov 24
Form 4
5.89%
464.50K
$9.89
$4.59M
Apr 13, 2021
13.71M
Purchase
Apr 09 - Apr 13
Form 4
103.57%
11.05M
$10.00
$25.00M
Feb 12, 2021
21.71M
Options
Feb 10
Form 4
390.00K
$10.00
$3.90M
Jul 06, 2020
390.00K
Purchase
Jul 06
Form 3
Jun 30, 2020
Showing 7 results

Kura Oncology, Inc.

Investor
Updated Jan 10, 2019
Form 4
4.44%
187.37K
$13.39
$2.55M
Jan 10, 2019
4.41M
Purchase
Dec 17 - Dec 21
Form 4
0.97%
40.54K
$13.90
$563.36K
Dec 13, 2018
4.22M
Purchase
Dec 11 - Dec 13
Form 4
1.46%
119.91K
$13.50
$1.62M
Dec 06, 2018
8.34M
Purchase
Dec 03 - Dec 06
Form 3
Nov 05, 2018
4.06M
Form 3
Aug 21, 2017
3.06M
Showing 5 results

Panacea Acquisition Corp. II

Investor
Updated May 02, 2023
Form 4
-100.00%
-545.00K
May 02, 2023
Disposition
Apr 28
Form 4
545.00K
$10.00
$5.45M
Apr 13, 2021
545.00K
Purchase
Apr 09
Form 3
Apr 06, 2021
Showing 3 results

ASSEMBLY BIOSCIENCES, INC.

Investor
Updated Apr 18, 2018
Form 4
25.44%
246.00
$8.50
$2.09K
Apr 18, 2018
1.21K
Purchase
Apr 17
Form 4
967.00
$7.47
$7.23K
Apr 17, 2018
967.00
Purchase
Apr 13
Form 3
Jun 27, 2016
2.16M
Showing 3 results

aTYR PHARMA INC

Investor
Updated May 16, 2018
Form 4
-100.00%
-3.21M
$0.93
-$3.00M
May 16, 2018
Sale
May 14 - May 16
Form 4
0.49%
15.78K
$4.46
$86.86K
Dec 14, 2017
3.21M
Purchase
Oct 01 - Nov 13
Form 3
Sep 07, 2017
3.19M
Showing 3 results

GENVEC INC

Investor
Updated May 27, 2014
Form 4
1.23%
24.14K
$2.24
$54.08K
May 27, 2014
1.99M
Purchase
May 22 - May 27
Form 4
6.65%
122.27K
$2.55
$311.98K
Mar 28, 2014
1.96M
Purchase
Mar 26 - Mar 28
Form 3
Mar 28, 2014
736.46K
Showing 3 results